Antimalarial chemoprophylaxis for forest goers in southeast Asia: an open-label, individually randomised controlled trial - The Lancet Infectious Diseases
Ex Vivo Plasmodium malariae Culture Method for Antimalarial Drugs Screen in the Field | ACS Infectious Diseases
Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial - The Lancet
Recent Advances in Antimalarial Drug Discovery — Challenges and Opportunities | IntechOpen
Exploration of artemisinin derivatives and synthetic peroxides in antimalarial drug discovery research - ScienceDirect
8-Aminoquinoline Therapy for Latent Malaria | Clinical Microbiology Reviews
Review of Atypical Organometallic Compounds as Antimalarial Drugs
Disposition of Amodiaquine and Related Antimalarial Agents in Human Neutrophils: Implications for Drug Design | Journal of Pharmacology and Experimental Therapeutics
Molecules | Free Full-Text | Bioactivities and Mode of Actions of Dibutyl Phthalates and Nocardamine from Streptomyces sp. H11809
JCM | Free Full-Text | COVID-19 Infection in Rheumatic Patients on Chronic Antimalarial Drugs: A Systematic Review and Meta-Analysis
Parasitologia | Free Full-Text | Antimalarial Drug Strategies to Target Plasmodium Gametocytes
Antimalarial and anticancer properties of artesunate and other artemisinins: current development | SpringerLink
Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study - The Lancet Infectious Diseases
The disposition of amodiaquine in Zambians and Nigerians with malaria. - Abstract - Europe PMC
Discovery and Preclinical Pharmacology of INE963, a Potent and Fast-Acting Blood-Stage Antimalarial with a High Barrier to Resistance and Potential for Single-Dose Cures in Uncomplicated Malaria | Journal of Medicinal Chemistry
Comparison of the Primary Outcome, by the Peto Odds Ratio (OR) Method | Download Table
Hybridization of Fluoro-amodiaquine (FAQ) with Pyrimidines: Synthesis and Antimalarial Efficacy of FAQ–Pyrimidines | ACS Medicinal Chemistry Letters
The antimalarial MMV688533 provides potential for single-dose cures with a high barrier to Plasmodium falciparum parasite resistance | Science Translational Medicine